康基醫療(09997.HK)訂立土地收回協議
格隆匯5月13日丨康基醫療(09997.HK)公告,2023年12月28日,賣方(Hangzhou Kangji Medical Instrument Co., Ltd.,爲公司的間接全資附屬公司)與買方(Hangzhou Yonghao Carefree Cultural Development Co., Ltd.,爲公司及其關連人士的獨立第三方)訂立股權轉讓協議,據此,買方已同意購買目標公司的全部股權,總代價爲人民幣3.66億元。目標公司(即Hangzhou Kangji Qipu Medical Instrument Co., Ltd.,)爲一家醫療器械公司及公司的間接全資附屬公司。目標公司主要從事醫療器械的分銷及研發。
於2025年5月13日,賣方、買方與目標公司,除其他外,訂立和解協議。據此,訂約方已不可撤銷地同意終止股權轉讓協議,自和解協議日期起生效。
於2025年5月7日,目標公司與中國政府機構蕭山經濟技術開發區管理委員會(爲公司獨立第三方)訂立土地收回協議。據此,政府機構同意就收回目標公司持有的特定地塊向目標公司支付約人民幣29.3百萬元。根據土地收回協議,目標公司須於2025年5月31日前將該地塊轉讓予政府機構。集團預計於和解協議及土地收回協議完成後將實現收益約人民幣39.3百萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.